Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 6 hours ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 2 days agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 2 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Pfizer Shareholders Reject Political Spending, Lobbying Proposal
Bloomberg Law· 6 hours agoPfizer investors dismissed a proposal that would have required the drugmaker to disclose how its political donations square with its publicly stated values, at the company ...
A shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact...
Phys.org· 1 hour agoResearchers at CeMM, in a collaboration with Pfizer, have now leveraged and scaled a method to...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 3 hours agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology. The complaint relates to patents discovered by researchers who ...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 9 hours agoBristol Myers’ growth in the near term will be hampered by looming patent expirations for its two...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 1 day agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...